JPRN-jRCTs051180220招募中2 期
Paclitaxel plus cisplatin as adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIB cervical cancer
Sumi Toshiyuki0 个研究点目标入组 125 人开始时间: 2019年3月27日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 125
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 75age old（—）
- 性别
- Female
入选标准
- •(1) Uterine cervical cancer confirmed by histology
- •(2) Pathological findings
- •More than half cervical stromal invasion and positive lymphovascular space invasion
排除标准
- •(1) Active infection
- •(2) Severe complication
- •(3) Multiple primary cancers with disease-free period less than 5 years, except carcinoma in situ or intra mucosal disease curedby local therapy
- •(4) Interstitial pneumonia, pulmonary fibrosis
- •(5) Massive ascites, massive pleural infusion
- •(6) Allergy to paclitaxel or cisplatin
- •(7) Severe allergy to medicine
- •(8) The patient who is not safe to include in this study
研究者
相似试验
已完成
2 期
eoadjuvant chemotherapy with Paclitaxel/Bevacizumab followed by FEC (5-Fluorouracil/Epirubicin/Cyclophosphamide) for triple negative operable primary breast cancerbreast cancerJPRN-UMIN000010228Department of Surgery, Division of Breast and Endocrine Surgery, St. Marianna University School of Medicine20
招募中
2 期
Concurrent paclitaxel and carboplatin-based chemoradiotherapy for stage III or IVA cervical cancer with renal dysfunctioCervical cancerJPRN-jRCTs031180165Imai Yuichi32
已完成
2 期
Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast CancerBreast CancerNCT00930930Vanderbilt-Ingram Cancer Center145
已完成
1 期
Paclitaxel plus cisplatin and concurrent radiation for unresectable, locally recurrent or remnant gastric cancer in the left upper abdomen – phase I studyunresectable, locally recurrent or remnant gastric cancerJPRN-C000000246Multi-modality therapy for gastric cancer study group6
已完成
不适用
Paclitaxel plus carboplatin for advanced or recurrent carcinosarcoma of the uterus in Japan.advanced or recurrent carcinosarcomaJPRN-UMIN000008390Gynecology, Tohoku University Hospital35